LegoChem Biosciences, Inc.
KOSDAQ 141080.KQ
LegoChem Biosciences, Inc. Interest Coverage Ratio for the year ending December 31, 2023: -143.98
-
LegoChem Biosciences, Inc. Interest Coverage Ratio for the year ending December 31, 2022 was -166.19, a 44.46% change year over year.
-
LegoChem Biosciences, Inc. Interest Coverage Ratio for the year ending December 31, 2021 was -299.20, a -100.00% change year over year.
-
LegoChem Biosciences, Inc. Interest Coverage Ratio for the year ending December 31, 2020 was 24,801,467.39, a 4,874,864.43% change year over year.
-
LegoChem Biosciences, Inc. Interest Coverage Ratio for the year ending December 31, 2019 was 508.75, a 343.24% change year over year.
| Date | Interest Coverage Ratio | Debt to Equity Ratio | Interest Expense To Sales | Inventory Turnover Ratio |
|---|
| CEO | Mr. Yong Zu Kim Ph.D. |
| IPO Date | May 10, 2013 |
| Location | |
| Headquarters | 10, Gukjegwahak 10-ro |
| Employees | 157 |
| Sector | Health Care |
| Industries | |
LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email